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Abstract 
Regulatory elements (enhancers) that are remote from promoters play a critical 
role in the spatial, temporal and physiological control of gene expression. 
Studies on specific loci, together with genome-wide approaches, suggest that 
there may be many common mechanisms involved in enhancer-promoter 
communication. Here, we discuss the multi-protein complexes that are 
recruited to enhancers and the hierarchy of events taking place between 
regulatory elements and promoters.  
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Glossary 
DNase Hypersenstive Site (DHS): Open region in the genome with increased 
chromatin accessibility to DNaseI that may reflect the occupation by a transcription 
factor or the disruption of nucleosome structure. DHS form nucleosome free regions 
(NFR).  
Pioneer Transcription Factors: Transcription factors that can bind their target sites 
at nucleosomal DNA. This facilitates chromatin remodelling and the binding of other 
transcription factors with the formation of open chromatin regions (DHS) before 
enhancer/promoter activation. They also have the property of being retained on 
mitotic chromosomes and thus could serve as “bookmarking” proteins in mitosis.  
Relay Transcription Factors: Transcription factors from the same family (e.g. SOX, 
GATA) relaying each other for the same binding site (exchange model) as they are 
expressed at different stages during gene priming. 
Transcription Start Site (TSS): Nucleotide marking the site of initiation of mRNA 
transcription.  
Enhancer: Regulatory sequence that increases the rate, or the probability, of 
transcription of a target gene. An enhancer may lie far away, upstream or 
downstream from the gene it regulates or may be located in an intron of its target 
gene or indeed in an intron of another gene.  
Locus Control Region (LCR): Genomic region that has the ability to confer 
physiological levels of tissue-specific expression on a gene linked in cis, independent 
of the gene’s integration site. A LCR can open silent chromatin.  
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General Transcription Factor (GTF): Also referred to as basal transcription factors 
(TFIIA, TFIIB, TFIID, TFIIE, TFIIF and TFIIH) that bind to core promoters.  
Pre-initiation complex (PIC): Association between GTF and RNA polymerase II. 
PolII Holocomplex: Complex of subunits forming the complete enzymatically active 
form of PolII. 
Paused PolII: After promoter escape, the engaged PolII is stalled at a pause site, 
waiting for further signals to progress during elongation. 
C-terminal domain (CTD): The C-terminal domain (CTD) of the largest subunit of 
RNA Polymerase II (PolII) consists of an array of repeats of a heptapeptide sequence 
(52 repeats in mammals). Amino acids in these repeats are targets for post-
translational modification such as phosphorylation of serine 5 (Ser5P) - associated 
with early elongation (or the paused state of PolII) and Ser2P associated with full 
elongation.  
Activator: Trans-acting factor binding a DNA sequence to activate the transcriptional 
activity of a target gene. 
Co-activator: Non-DNA binding protein that associates with an activator and 
enhances transcription.  
Mediator: Large co-activator complex containing 30 subunits in metazoans 
distributed in three modules: the head, the middle and the tail. Mediator is conserved 
throughout all eukaryotes. 
Integrator: Large co-activator complex containing at least 14 subunits with a total 
MW over 1MDa. Integrator is restricted to metazoans.  
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The core promoter 
Genes transcribed by RNA Polymerase II (PolII) usually have two distinct families of 
cis-acting elements: the promoter [≤ 1 kb from the transcription start site (TSS)] - 
composed of a core promoter 1, 2 and nearby (proximal) regulatory elements 3, 4, and 
more remote (distal) cis-regulatory elements (≥ 1 kb from TSS), which can be 
enhancers, silencers, insulators or locus control regions (LCR) 3. The exact 
composition of core promoter elements may be a key determinant of enhancer-
promoter specificity 5 6. In mammalian genomes, enhancers are enriched in core 
promoter elements but are CpG poor whereas promoters are generally CpG rich 7 8. 
Beside the CpG content, enhancers and promoters have broad similarities and 
overlapping functional properties, and have been considered to form a single class of 
regulatory element 9.  
The core promoter represents the docking site for the General Transcription Factors 
(GTFs), including TFIIA, TFIIB, TFIID, TFIIE, TFIIF and TFIIH, which, together with 
PolII, form the pre-initiation complex (PIC) 10. The PIC is thought to assemble on the 
core promoter in a specific and sequential order that directs PolII to the nearby TSS 
10. However, this is only sufficient to direct low levels of accurately initiated 
transcription from DNA templates in vitro, a process generally referred to as basal 
transcription.  
The first step in PIC assembly is binding of TFIID, a multi-subunit complex consisting 
of TATA-box-binding protein (TBP) and a set of 14 TBP-associated factors (TAFs) 10. 
Transcription then proceeds through a series of steps, including promoter melting, 
clearance and escape, before fully functional PolII elongation is achieved. Alternative 
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core promoter complexes may help to maintain specific transcriptional programs in 
terminally differentiated cell types 11 12 13 14.  
Models of transcription regulation view this as a cycle, in which complete PIC 
assembly is stimulated only once. After PolII escapes from the promoter, TFIID, 
TFIIE, TFIIH and the Mediator complex (see glossary) remain on the core promoter; 
subsequent re-initiation then only requires de novo recruitment of sub-complexes 
comprising Pol II-TFIIF and TFIIB (Reviewed in 15). The various steps of PIC 
assembly on a core promoter can occur with different timings during differentiation. 
For example, TBP is already bound to the promoters of D1-AT, HNF-4D, VpreB1 and 
O5, long before differentiation and the transcriptional activation of these genes 16 17. 
Additional transcription factors (TFs) and PolII are recruited later when the genes are 
transcribed. The one-step recruitment of a (pre-)formed holocomplex (see glossary) 
at promoters has been also described 18-21. However, it is worth noting that the right 
temporal window to appreciate the dynamics of PIC recruitment is often missing from 
most studies. 
In metazoans, the transition from initiation to productive elongation is another 
important step that involves several levels of regulation. In a region between 30-60 
nucleotides downstream the TSS, PolII is often found stalled and thus paused at this 
site, awaiting additional signals for full elongation 22. The release of paused PolII is 
controlled by several TFs such as the negative elongation factor (NELF), the DRB 
sensitivity-inducing factor (DSIF) and the transcription elongation factor P-TEFb 
complex (CDK9 and cyclin T). P-TEFb is part of a larger multisubunit complex, called 
super elongation complex (SEC) 23. The CTD of PolII plays an important role in 
elongation by its phosphorylation at several residues (see glossary). Recently, a new 
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multiprotein complex, termed Integrator, has been shown to regulate elongation by 
recruiting the SEC 24.  
Large protein complexes are bound to promoters and 
enhancers 
Transcription is greatly stimulated by a second class of TFs, termed activators. In 
general, activators are sequence-specific DNA-binding proteins whose recognition 
sites are usually present near the core promoter and/or at enhancers. Binding of TFs 
at these elements usually corresponds to nucleosome free regions (NFRs) 
characterised by hypersensitivity to digestion by nucleases (DNase Hypersensitive 
Sites, DHS)2, 25, 26.  This open-chromatin structure can be facilitated by chromatin 
remodelling factors, which are recruited by TFs and modify histones of the nearby 
nucleosomes.  
Binding of activators does not stimulate transcription from chromatinised templates in 
vitro. The search for factors that stimulate activator-dependent transcription led to the 
identification of co-activators including; Mediator complexes 27, 28, CBP 29, p300 30 
and BAF 31. TFs recruit co-activators that can then modify chromatin and/or interact 
with the core transcription machinery.  
The large multiprotein Mediator complex can act as a bridge between transcription 
activators and components of the PIC 32 (see below). It appears to play important 
roles in many steps of transcription, including PIC formation and the transition to 
elongation 32. Mediator is over a megadalton (MDa) in size and 30nm in length, with 
distinct structural modules and a flexible structure that changes in response to the 
binding of different TFs 33. TF binding seems to induce a conformation change in 
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Mediator that facilitates PolII binding. Different TFs bind different Mediator subunits, 
and Mediator complexes that lack a specific subunit can still activate transcription in 
response to TFs that bind to other subunits. Therefore, among other proteins (e.g. 
CTCF and cohesin complex) not described in this review, Mediator provides a very 
important bridge for integrating information coming from different signalling pathways. 
Mediator might also provide an important binding surface for non-coding RNAs, 
including eRNAs (see below). 
Other co-activators are ATP-dependent chromatin remodelling factors (such as 
Brahma-associated factor – BAF), or histone acetyltransferases (HAT) – p300/CBP. 
These can be part of the same complexes. ATP-dependent chromatin-remodelling 
families form different complexes by a combinatorial assembly of many subunits, to 
produce biological specificity 34. BAF complexes, which belong to the SWI/SNF family 
of ATPase dependent chromatin remodelling complexes, are involved in the 
relaxation of higher-order chromatin structures and in nucleosome movement and 
exchange 35. The p400 SWI/SNF is associated with a HAT (TIP60) in the Tip60/p400 
complex that is involved in histone (H2A/H2A.Z) exchange. CREB-binding protein 
(CBP) and its paralog p300 are co-activator HATs that are found at both promoters 
and enhancers, and chromatin immunoprecipitation (ChIP) for p300/CBP, together 
with H3K27ac, is often used to identify active enhancers 36, 37. However, this is 
unlikely to be a universal signature of all active enhancers. Indeed, another class of 
enhancers, containing H4K16ac and KAT8 (MYSM1) but not p300 and H3K27ac 
have been recently described in embryonic stem (ES) cells 38. Moreover, HATs also 
have important non-histone substrates and the role of this in enhancer function is 
under-studied 39. Other HATs and HAT-containing complexes (SAGA/PCAF) also 
have co-activator activity 40.  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
9 
One of the main questions that needs to be addressed is at which step during gene 
activation do various nucleoprotein complexes assemble at distant enhancers, and 
how do these complexes then contribute to promoter accessibility, PIC recruitment 
and/or assembly, transcription initiation and transcription elongation? Enhancers 
have been shown to have a role in: PIC recruitment at target promoters 21, 41-45, 
removing proteasome complexes at promoters 46, the generation of intra-
chromosomal loops between regulatory regions 47, and the regulation of elongation 
18, 48-51. Enhancers are also involved in the removal of repressive histone 
modifications 41, 52-57, suggesting that they also contribute to the delivery of enzymes 
that regulate histone modifications 58.  
Below, we compare studies that have been done in a few mammalian loci in enough 
depth to provide significant mechanistic insight. Together with supportive genome-
wide studies, we discuss if there are common principles that govern the regulation of 
enhancer-driven transcription.  
Sequential recruitment of factors to enhancers and 
promoters 
It is now well established that genes are primed for expression by the binding of 
pioneer TFs (see glossary) generating nucleosome free regions at regulatory 
elements and bookmarking the genome for gene expression at a later stage of 
differentiation 59-63 (Figure 1A). Enhancer priming is followed by the replacement or 
recruitment of additional TFs (namely relay, tether and trigger, see glossary and 
below), which may be recruited in a sequential order, mirroring a similar phenomenon 
on core promoters (e.g. PIC assembly).  
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Pioneer TFs are able to disrupt chromatin structure and bind to their cognate binding 
sites irrespective of nucleosomes that may be occluding these sequences (Figure 
1A) 64 65, although this is dependent on the context of other TFs that they associate 
with in a particular cell type 66, 67. Pioneer factors, together with chromatin 
remodelling complexes, are therefore involved in generating an NFR to facilitate the 
binding of other TFs (Figure 1B). Table 1 lists TFs that have been reported to have 
pioneer activity. The DNA-binding domain (winged-helix DNA-binding 
domain/forkhead) of TFs such as HNF3 (FoxA) resembles that of linker histones H1 
and H5 and therefore could be involved in chromatin opening by altering nucleosome 
structure 68. The CCAAT Box binding factor, NFY has also a core histone-like 
structure 69 and has been suggested to be involved in opening chromatin by 
nucleosome replacement 70 58 and facilitating the binding of master regulators to 
enhancers in ES cells 71. It has been suggested that the pioneer activity of PU.1 - a 
hematopoietic pioneer factor TF - may relate to the tighter DNA-binding of its ETS-
domain compared to that of other ETS-family TFs 72. In reprogramming of somatic 
cells, Oct4, Sox2, and Klf4 act as pioneer factors, binding at closed chromatin sites 73 
65.  Importantly, their binding occurs first at distal enhancers during early 
reprogramming steps (Figure 1A), whereas promoter occupancy is a much later 
event 74 (Figure 1B). The formation of NFRs at promoter and enhancer occur 
independently from each other. Enhancer priming by pioneer TFs in specific cell-
lineages provides a chromatin landscape that can then direct cell-type-specific 
responses to TFs that act downstream of generic signaling pathways 75-79. 
Pioneer TF DNA binding domain References 
AP-1 Basic leucine zipper 76 
AP-2J (TFAP2C) Basic helix-span-helix 80 
FOXA1 (HNF-3D) Forkhead 81, 82 
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FOXA2 (HNF-3E) Forkhead 68, 83 
FOXE1 Forkhead 84 
FOXD3 Forkhead 68, 83 
GATA2 2X GATA-type zinc fingers 20 
GATA3 2X GATA-type zinc fingers 85 
GATA4 2X GATA-type zinc fingers 68, 85, 86 
KLF4 3X C2H2-type zinc fingers 73 
NF-Y (CBF) NF-YA/HAP2 70, 71 
OCT4 POU-specific + POU-
Homeodomain 
73 67 
OTX2 Homeodomain 67 
PAX7 Paired + Homeodomain 87 
PBX1 Homeodomain 88 
PU.1 Ets 66, 72, 75 
SOX2 Hmg box 73, 89, 90 
SOX9 Hmg box 91 
TP53 p53 92 
P63 p53 92 
RFX Rfx-type winged helix 93 
Table 1. Pioneer transcription factors involved in DHS formation prior to gene 
activation.  
Pioneer TFs may remain bound throughout the stages of enhancer activation, or they 
can be replaced by other TFs (exchange model with relay TFs, see glossary) 20, 89, 94. 
In some cases, PIC recruitment to enhancers has been reported early during 
enhancer priming 17, 19, in other cases this is a late event 21. The first situation led to 
the idea that enhancers act as a docking site for the recruitment of the general 
transcription machinery (Figure 1C) that would then be subsequently transferred to 
the promoter (Figure 1D) 95 96 97. However, many studies have shown that levels of 
PIC occupancy at enhancers – as judged by ChIP - often appear to be relatively low 
compared to those at promoters 98. This could be explained by i) one PIC being 
spread across the enhancer sequence, which is larger than a core promoter (Figure 
1C), i) by the transient nature of several PICs binding to those sequences, or ii) by 
indirect binding of PICs.   
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Apparent differences in the timing of recruitment of PIC components to a promoter 
either before 16, 17, 99, or at the onset of mRNA transcription 18, 21 might be due to the 
different role(s) attributed to the enhancers, but also to the presence of other 
important elements located nearby in the proximal promoter. For example, deletion of 
the Sp1 site at the T-cell receptor beta (TCRE) promoter, and the CAAT or CACCC 
boxes at the J globin promoter, result in failure to detectably recruit TBP at the 
promoter 100-102, suggesting that these proximal promoter elements are needed to 
recruit the PIC in order to form a full “promoter complex”.  
Transcription from enhancers and promoters 
Enhancers are required for transcription of target genes  
Genetic ablation is a powerful approach to address how enhancers influence TF and 
PolII assembly/elongation at promoters. Table 2 summarize the few studies on single 
loci addressing this, together with the mechanisms of enhancer-promoter 
communication (see relevant section below). Supporting independent GTFs and PolII 
recruitment at enhancers and promoters, a few studies have shown that removing a 
promoter does not affect GTFs or PolII recruitment at the enhancer 21, 103, but 
removing the enhancer affects GTFs or PolII binding at the promoter 21, 41-44.  
Other studies have shown that deletion of enhancers also affects downstream events 
such as elongation through PolII phosphorylation 18; 48 3, 49. Release of paused PolII 
might also require additional TFs or additional enhancers 45, 104 (Figure 2C). PolII 
elongation is regulated by several kinases (cdk7/TFIIH, cdk8/Mediator, and cdk9/p-
TEFb) and these are all recruited to genes when expressed 21 48 and may be 
delivered through the enhancers 105 106. This is consistent with genome-wide studies 
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showing Ser5P 98 and Ser -2P 107, 108 phosphorylated forms of PolII at active 
enhancers, supporting the idea that enhancers can deliver an activated PolII to target 
promoters. Alternatively, other regulators of elongation such as DSIF and FACT 49 
may be also involved and this idea has been strengthened by recent studies showing 
the binding of the Integrator at both enhancers and promoters 109. Overall, the current 
model arising from these studies is that the promoter is not needed to recruit PolII at 
enhancers, but the enhancer is always needed to recruit PolII at the promoter or for 
downstream events such as elongation. Beside these studies, it is worth noting that 
the timing of an enhancer deletion might also influence outcomes. Enhancers might 
be required for the initiation of a transcription event whereas others might be 
important for the maintenance of transcription. For example, histone modifications 
controlled from a transiently required enhancer might remain after a conditional 
deletion 110 111.  
Enhancers are also transcribed  
Many of the scenarios described above appear to blur the distinction between 
enhancers and promoters. This is further compounded by evidence of transcription 
and the production of short RNAs at enhancers (eRNAs) 112 103, 113 (Figure 1D). The 
level of expression of these eRNAs is low but positively correlates with the level of 
mRNA synthesis at nearby genes 103. eRNAs are short and unstable, probably 
because the absence of downstream exons (5’ splice donors), or the presence of 
other signals, fails to stabilise the production of the transcribed RNA 114 and indeed 
the degradation of eRNAs by the exosome is important to prevent the formation of 
deleterious RNA/DNA hybrids 115. Note that intragenic enhancers can also function 
as alternative gene promoters – being spliced to downstream exons to produce 
stable mRNAs 113. Conversely, promoters can also work as enhancers 9, 116. Thus, 
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the distinction between enhancers and promoters lies to some extent simply in their 
genomic context.  
The biological relevance of eRNAs remains controversial as it is still unclear if eRNAs 
are byproducts of transcription or if they have regulatory functions in themselves. 
Bidirectional eRNA transcripts can be detected at early stages, prior to the 
appearance of H3K4me1 at enhancers 79 and to the production of mRNA from the 
target genes 7 117 51, 118, 119. This could be associated with early recruitment of PolII at 
enhancers by pioneer TFs 120. Several attempts at elucidating the role of eRNAs 
have been addressed by knockdown approaches, showing transcription down-
regulation from some 121, 117, 122, 123, 124, 125, but not all, target promoters 118. Other 
studies, using a more robust approach, that remove the promoter of the target gene 
were also not conclusive: in the absence of the Arc promoter, eRNA synthesis is 
abolished, suggesting that it is mRNA dependent 103 3; whereas no effect was 
observed in the same type of experiments on the human growth hormone (hGH-N) 
locus 126.  One study has proposed that eRNAs act as decoy molecules to release 
NELF from paused PolII at immediate early genes 51. This is interesting because, this 
scenario was supported by a recent study showing that the Integrator, is also 
recruited to enhancers 109. Integrator is required for the full processing of eRNAs, and 
depletion of Integrator subunits reduces the production of eRNAs and abolishes 
enhancer-promoter communication 109. As Integrator controls the elongation of 
mRNA transcription of the genes regulated by paused PolII, the role of eRNAs may 
depend on the context of elongation regulation of as only 50% of genes are regulated 
by such mechanism 22. 
 
Enhancer-promoter communication  
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Enhancers can be separated from promoters by distances ranging from a few 
kilobases to a little over one thousand kilobases 127, yet transcriptional regulation 
requires some kind of communication between these distant elements (Figure 2). It is 
still unclear what form this communication takes, e.g. what are the molecules that are 
transmitted between regulatory element and promoter, when this takes place, and 
whether this is the same for all classes of enhancers. 
Historically, a linking model suggested that an activator protein (eg pioneer Figure 
1B) first binds the promoter at a proximal sequence and facilitates the recruitment of 
a second TF to a site located just downstream the former 90, 128, 129. This cascade of 
recruitment occurs until it reaches the core promoter to finally recruit the PIC 21, 99.  
The tracking model and/or a facilitated tracking model (Figure 2) is described as a 
mechanism by which enhancer bound proteins move progressively in an 
unidirectional manner towards the promoter sometimes without leaving the enhancer 
sequence, and thus results in the formation of a progressive loop that increases its 
size until it reaches the promoter to form a stable conformation 99, 130-132 (Figure 2A). 
In this model, histone acetylation and TF complexes are transiently detected in the 
intervening sequence and precedes transcription. Originally, it was proposed that 
intergenic transcripts (eRNAs) are just involved in maintaining an open chromatin 
structure 133. Once the gene is expressed, additional transcripts (mostly 
unidirectional) have been detected across the intervening sequence between 
enhancers and promoters, which could reflect the tracking of an active PolII 17 43 
(Figure 2A).  
The looping model implies a direct interaction between two chromosomal regions by 
looping out the intervening DNA sequence. Various proteins bound at enhancers and 
promoters have also been proposed to bridge enhancers and promoters together in 
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as looped chromatin structures. These include TFs, such as TAF3 134, GATA1 135, 
EKLF 136, Brg1 137, Ldb-1 138, Mediator 139, CTCF 140, SATB1 141 and cohesins 3, 142-
144. eRNAs have also been proposed to be physically involved in establishing 
enhancer-promoter ‘looping’ 124, and involving the Integrator 109. 
The stiffness of the chromatin fibre might restrict short-range enhancer-promoter 
interactions, with a minimal estimated length of 10kb for uninterrupted 30nm 
chromatin fibres and 0.5kb for naked DNA 145, 146. NFRs – e.g. created by pioneer 
TFs - could thus act as hinges, to facilitate chromatin bending and thus the formation 
of short loops 146 147.  
Given the larger distance (> 10 kb and up to 100s of kb) separating many enhancers 
from their target promoter it is difficult to envisage a mechanism in which the 
intervening chromatin is directly involved in a mechanism of enhancer-promoter 
communication such as tracking. Therefore tracking mechanisms are likely limited to 
enhancers that are close (1-10kb) to their target promoters (Figure 1D). Indeed, the 
two cases where a facilitated-tracking mechanism has been described, involve a 
moderate enhancer - promoter distance (Table 2) 99, 132, in comparison to intra-
chromosomal looping which has been described for longer enhancer-promoter 
distances (Table 2) 47, 135, 148, 149. In the latter cases: do random collisions suffice to 
facilitate these interactions, or do enhancers actively “seek” for targets both 
downstream and upstream with equal frequency? Clustered enhancers such as 
LCRs may be formed by sequential priming progressing from the most upstream 
element to those downstream, generating a directionality toward the final target 
promoter 130. An upstream enhancer (MCS-R2) of the D-globin locus, when relocated 
downstream of the target genes, still requires interactions with the other upstream 
enhancers for globin transcription 47 (reviewed in 58). A polarity between several 
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enhancers has also been shown with the E-globin locus 150. Deletion of the MCS-R2 
D-globin enhancer decreases TF occupancy from the most upstream enhancer 
towards the downstream promoter 53, 58 again suggesting a directionality in the signal. 
The duplicated D-globin genes in most species have similar or identical promoters, 
and it is the gene closest to the upstream elements, that is usually expressed at the 
higher level (reviewed in 151). When more than two D-globin genes are present in cis, 
the additional genes lying downstream are expressed at even lower levels 152. Thus, 
it is conceivable that these mechanisms might all be used to regulate a single gene: 
a looping mechanism between enhancers and promoter for long distance 
interactions; a tracking mechanism between the different genes of the same cluster, 
and finally, a linking mechanism between the proximal and the core promoter. 
Studies using 3C technology and its variations have tended to concentrate attention 
on long-range interactions, and therefore may have distracted from other possible 
mechanisms. A study showed that latent enhancers induced by a given stimulus 
were shown to be frequently at a short distance from target genes 153; therefore more 
studies analysing proximal enhancers are needed to characterise the nature of other 
mechanisms of enhancer-promoter communication. 
Concluding Remarks 
BOX1: Outstanding questions 
x Why PolII recruitment at enhancers sometimes occurs early, long before 
transcription, and sometimes late, when transcription occurs? In the first scenario, 
eRNA production might be important for downstream events. 
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x What is the order of events leading to gene transcription during differentiation or 
hormonal stimulation, and which feature is cause vs consequence? Molecular 
dissection of appropriate model loci are required to address these questions. 
x Do random collisions suffice to facilitate enhancer-promoter interactions, or do 
enhancers actively “seek” for targets both downstream and upstream with equal 
frequency? 
 
x Does increased enhancer-promoter distance in higher organisms favour particular 
mechanisms of interactions between these elements, e.g. looping rather than 
tracking or linking? 
 
x What mechanism would a gene use if the intervening DNA sequence is 
increased, or abolished, or if a ‘linear tracking blocker’ is inserted? 
 
Some genes are regulated by several remote enhancers located at distances that 
vary from 1Kb to up to 1Mb. There are also genes in clusters that are regulated by 
the same remote enhancer (e.g. globin genes). Although these genes can be 
expressed at different stages of development or in different tissues, they are all 
expressed in the same orientation and their expression level often reduces with 
increasing distance from the enhancers 44, 151, 152. During differentiation, enhancers 
are first primed by pioneer TFs 59, and the signal is subsequently replaced by relay 
TFs (exchange model). Then, it spreads or loops towards the downstream promoter 
via other TFs. There is thus a hierarchy among these elements involving a sequential 
recruitment of TFs, generating the polarity of the transcription signal, from the remote 
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enhancers towards the promoter they regulate. Most of these enhancers have a role 
as centres of recruitment of PIC. On one hand, the role of the enhancer would be to 
deliver the PIC to the promoter, and thus explain the enhancer-dependence for PIC 
recruitment at the promoter. On the other hand, the mechanism(s) that prevent(s) this 
transfer at the early stages of activation is unclear. Enhancers and promoter seem to 
communicate by i) physical association and formation of chromosomal loops – in 
which the intervening DNA sequence would seem to be irrelevant (Looping Model, 
Figure 2B) or ii) by spreading a signal though the intervening sequence separating 
enhancer and promoter (Facilitated-Tracking Model) (Figure 2A). Although short 
distances between these elements are usually found in simpler organisms, the 
distance has increased in higher organisms. Has this increased distance favoured 
other mechanisms of interactions between these elements, e.g. looping rather than 
linking? What mechanism would a gene use if the intervening DNA sequence is 
increased, or abolished, or if a ‘tracking blocker’ is inserted. Originally, several 
studies have addressed the role of a tracking blocker using insulator elements (e.g. 
154). However, the caveats with such experiments, is that we know now that CTCF 
bound elements are involved in the 3D organisation of the genome in looped 
structures. Thus, the use of ‘linear’ tracking blockers such as the lac repressor 155 or 
TerF terminator 156) would be more appropriate, and only a couple of studies have 
addressed this 43, 157. Even for very long-range enhancers, these elements are 
capable of working at very short distances in enhancer reporter and transgene 
assays 158. There are many empty experimental boxes to be filled in Table 2, but we 
hope this review will help the research community to complete the puzzle. High-
throughput sequencing studies have enabled the genome-wide mapping of putative 
enhancers in diverse cell types.  Now functional analyses are required to provide the 
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mechanistic insight into how these enhancers work, and this will be facilitated by 
genome-editing strategies.   
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Figure 1. Multi-steps model of long-range gene regulation.  A. Enhancers are 
first primed by pioneer transcription factors binding to nucleosomal DNA. B. A 
nucleosome free region (NFR) is formed at an enhancer - often spanning more than 
one nucleosome. This provides a broad accessible platform for the recruitment of 
large protein complexes. A similar process occurs independently at the proximal 
promoter. The linking model suggests that an activator protein first binds the 
promoter at a proximal sequence and facilitates the recruitment of a second TF to a 
site located just downstream the former. This cascade of recruitment occurs until it 
reaches the core promoter. This builds a landing platform for the general transcription 
machinery to the TSS (angled arrow). C. The enhancer recruits very large protein 
complexes, including PIC and Mediator. D. The enhancer is now active and is 
associated with short bi-directional transcripts. Recruitment of PIC at the enhancer 
can precede that at the promoter, or may happen simultaneously. Proteins and 
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chromatin structures are drawn approximately to scale. Note that other complexes 
discussed in the text (e.g. Integrator, BAF, cohesins, etc) are not included for 
simplification.  
Figure 2. Mechanisms of enhancer-promoter communication.  A. The facilitated-
tracking model is described as a mechanism by which enhancer bound proteins 
move progressively in an unidirectionally manner towards the promoter, sometimes 
without leaving the enhancer sequence, and thus results in the formation of a 
progressive loop that increases its size until it reaches the promoter to form a stable 
conformation (B). In this model, histone acetylation and TF complexes are transiently 
detected in the intervening sequence and this precedes transcription. The tracking is 
associated with unidirectional transcripts detected in the intervening DNA sequence. 
B. The looping model implies a direct interaction between two chromosomal regions 
with the looping out of the intervening DNA sequence. A looped structure together 
with PolII recruitment at the promoter does not always correlate with transcription, but 
rather with paused PolII. C. Transcription elongation occurs after release of paused 
PolII, at the onset of looping or afterwards. As in Figure 1, proteins and chromatin 
structures are drawn approximately to scale. 
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Locus 
Enhancer (E) 
Intervening DNA (I) 
 
Prom
oter (P) 
 
Proposed 
M
echanism
 
References 
HS 
∆ E 
Size I 
∆ I 
Genes 
∆ P 
M
ouse Shh 
One HS 
√ 
800kb 
x 
1 
X 
Looping 
159 
M
ouse D-globin 
M
CSR1-4 
M
CS-R2 
20-40kb 
x 
2 
X 
Looping 
20, 21 
Hum
an D-globin 
M
CSR1-4 
M
CS-R2 
M
CSR1-4 
30-60kb 
x 
2 
√ 
Looping 
21, 47 
M
ouse E-globin 
HS1-5 
HS1-5 
40-60kb 
x 
2 
X 
Looping 
19, 135, 160 
Hum
an E-globin 
HS1-5 
HS2-3 
 
 
1 
√ 
Looping 
161 
Hum
an H-globin 
HS-2 
x 
10kb 
√ (Ins) 
1 
X 
Facilitated 
Tracking 
162 
Hum
an hGH 
HS1-5 
HS1 
20-35kb 
√ (Ter) 
5  
X 
x 
42, 43 
Hum
an Serpin 
HS1-4 
? 
1-5kb 
x 
4 
X 
x 
16, 44, 163 
M
ouse O5-VpreB1 
HS7-9 
x 
4kb 
x 
2 
X 
x 
17, 46 
Hum
an HNF-4D 
One HS 
x 
6.6kb 
x 
1 
X 
Facilitated 
Tracking 
99 
Hum
an PSA 
One HS 
x 
4.2kb 
x 
1 
X 
Facilitated 
Tracking 
95, 132, 164 
M
ouse TCRE 
One HS 
√ 
15kb 
x 
1 
√ 
Facilitated 
Tracking 
41, 101 
Hum
an HLA-DRA 
One HS 
x 
2.3kb 
x 
1 
X 
x 
93, 165 
M
ouse Arc locus 
One HS 
x 
7kb 
x 
1 
√ 
Looping 
51, 103 
 
Table 2. List of loci that have been analysed by deletion (∆) of E
nhancers (E
) or P
rom
oters (P
) and the m
echanism
s proposed for these interactions. 
The num
ber of enhancers (hypersensitive sites, HS) and genes they contain are shown. Note that for the hum
an H-globin and hGH genes, the Intervening DNA 
sequence (I) has been targeted by insertion of an insulator (Ins) or a term
inator (Ter) elem
ent respectively. Deletion of the prom
oter of the m
ouse TCRE gene 
includes an Sp1 binding site. , Abbreviation: HS: Hypersensitive site. √ : Available, and x: no study yet perform
ed. 
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The hierarchy of transcriptional activation: from enhancer to 
promoter 
Douglas Vernimmen & Wendy A. Bickmore 
Trends Box: 
x Enhancers are first primed by pioneer transcription factors. 
x Other transcription factors are likely required for subsequent events. 
x There is a hierarchy between enhancers and the promoters that they 
regulate. 
x Enhancers and promoters share similar properties, but differ in the 
characteristics and the abundance of the RNAs that they produce.  
x By recruiting the pre-initiation complex and other proteins, enhancers 
have a role of increasing the concentration of the transcription machinery 
at target promoters. 
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Douglas Vernimmen & Wendy A. Bickmore 
BOX1: Outstanding questions 
x Why PolII recruitment at enhancers sometimes occurs early, long before 
transcription, and sometimes late, when transcription occurs? In the first 
scenario, eRNA production might be important for downstream events. 
x What is the order of events leading to gene transcription during differentiation 
or hormonal stimulation, and which feature is cause vs consequence? 
Molecular dissection of appropriate model loci are required to address these 
questions. 
x Do random collisions suffice to facilitate enhancer-promoter interactions, or 
do enhancers actively “seek” for targets both downstream and upstream with 
equal frequency? 
 
x Does increased enhancer-promoter distance in higher organisms favour 
particular mechanisms of interactions between these elements, e.g. looping 
rather than tracking or linking?  
x What mechanism would a gene use if the intervening DNA sequence is 
increased, or abolished, or if a ‘linear tracking blocker’ is inserted? 
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